The effects of aldose reductase inhibitors in diabetic nephropathy.
McCormack
A J
AJ
Department of Medicine, University of North Carolina, Chapel Hill.
Finn
W F
WF
D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors*; D003928:Diabetic Nephropathies / Q000201:enzymology / Q000503:physiopathology*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D005919:Glomerular Filtration Rate; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000503:physiopathology; D007676:Kidney Failure, Chronic / Q000503:physiopathology; D013401:Sugar Alcohol Dehydrogenases / Q000037:antagonists & inhibitors*
D004791:Enzyme Inhibitors; D013401:Sugar Alcohol Dehydrogenases; D000449:Aldehyde Reductase